Induction of endothelial cell damage by hCMV molecular mimicry.

[1]  D. Reen,et al.  HSP60 induces self‐tolerance to repeated HSP60 stimulation and cross‐tolerance to other pro‐inflammatory stimuli , 2004, European journal of immunology.

[2]  W. Cushley,et al.  Positioning the immune system: unexpected roles for α6‐integrins , 2004 .

[3]  S. Ledbetter,et al.  A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. , 2004, Arthritis and rheumatism.

[4]  Qingbo Xu,et al.  Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.

[5]  P. Ljungman,et al.  Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus , 2004, Transplantation.

[6]  J. Laman,et al.  The Guillain-Barré syndrome: a true case of molecular mimicry. , 2004, Trends in immunology.

[7]  D. Girelli,et al.  Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis , 2003, The Lancet.

[8]  R. Hetzer,et al.  Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy , 2003, Transplantation.

[9]  G. Stouffer,et al.  Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Wright,et al.  Tetraspanins: molecular organisers of the leukocyte surface. , 2003, Trends in immunology.

[11]  A. Peleg,et al.  Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis , 2003, Clinical and Experimental Medicine.

[12]  M. Gershwin,et al.  In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. , 2003, Arthritis and rheumatism.

[13]  G. Ridgway,et al.  Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function , 2003, Circulation.

[14]  A Graham Pockley,et al.  Heat shock proteins as regulators of the immune response , 2003, The Lancet.

[15]  E. Hoffman,et al.  Murine Cytomegalovirus Infection Increases Aortic Expression of Proatherosclerotic Genes , 2003, Circulation.

[16]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[17]  D. Greaves,et al.  Inflammation and immune responses in atherosclerosis. , 2002, Trends in immunology.

[18]  L. Kasman,et al.  The role of infectious agents in the pathogenesis of systemic sclerosis , 2002, Current opinion in rheumatology.

[19]  M. Reddehase.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.

[20]  B. Horne,et al.  Serum Immunoglobulin G Antibodies to Chlamydial Heat Shock Protein 60 but Not to Human and Bacterial Homologs Are Associated With Coronary Artery Disease , 2002, Circulation.

[21]  M. Jarvis,et al.  Human cytomegalovirus persistence and latency in endothelial cells and macrophages. , 2002, Current opinion in microbiology.

[22]  L. McCormick,et al.  Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1 , 2002, The Journal of Immunology.

[23]  G. Millonig,et al.  Atherosclerosis as an autoimmune disease: an update. , 2001, Trends in immunology.

[24]  A. McMichael,et al.  Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. , 2001, Arthritis and rheumatism.

[25]  C. Benoist,et al.  Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? , 2001, Nature Immunology.

[26]  J. Nelson,et al.  The HCMV chemokine receptor US28 is a potential target in vascular disease. , 2001, Current drug targets. Infectious disorders.

[27]  A. Tedgui,et al.  Apoptosis as a Determinant of Atherothrombosis , 2001, Thrombosis and Haemostasis.

[28]  S. Blankenberg,et al.  Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease , 2001, Circulation.

[29]  A. Quyyumi,et al.  Antibodies to Human Heat-Shock Protein 60 Are Associated With the Presence and Severity of Coronary Artery Disease: Evidence for an Autoimmune Component of Atherogenesis , 2001, Circulation.

[30]  F. Marincola,et al.  Host Response to Cytomegalovirus Infection as a Determinant of Susceptibility to Coronary Artery Disease: Sex-Based Differences in Inflammation and Type of Immune Response , 2000, Circulation.

[31]  N. Sepp,et al.  Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. , 2000, Arthritis and rheumatism.

[32]  B. Horne,et al.  Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease , 2000, Circulation.

[33]  G. Damonte,et al.  Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells , 2000, Nature Medicine.

[34]  I. Mackay,et al.  Molecular mimicry: a critical look at exemplary instances in human diseases , 2000, Cellular and Molecular Life Sciences CMLS.

[35]  J. Cerny,et al.  The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[36]  G. Nuovo,et al.  CMV and Transplant-Related Coronary Atherosclerosis: An Immunohistochemical, In Situ Hybridization, and Polymerase Chain Reaction In Situ Study , 2000, Modern Pathology.

[37]  N. McHugh,et al.  Serologic abnormalities in systemic sclerosis. , 1999, Current opinion in rheumatology.

[38]  R. Gay,et al.  Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. , 1999, Arthritis and rheumatism.

[39]  V. Barnaba,et al.  Persisting viruses and chronic inflammation: understanding their relation to autoimmunity , 1998, Immunological reviews.

[40]  J. Piette,et al.  The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. , 1998, The Journal of clinical investigation.

[41]  H Cantor,et al.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. , 1998, Science.

[42]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[43]  M. Gershwin,et al.  Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. , 1996, The Journal of clinical investigation.

[44]  M. Debakey,et al.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.

[45]  C. Bona,et al.  Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes , 1992, The Journal of experimental medicine.

[46]  M. Gershwin,et al.  The immunopathology of progressive systemic sclerosis (PSS). , 1982, Seminars in arthritis and rheumatism.

[47]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[48]  M. Leinonen,et al.  Evidence for infectious agents in cardiovascular disease and atherosclerosis. , 2002, The Lancet. Infectious diseases.

[49]  J. P. Pandey,et al.  Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. , 1998, Arthritis and rheumatism.

[50]  K. Sugamura,et al.  Human parvovirus B19 in rheumatoid arthritis. , 1998, International reviews of immunology.